Oric Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.75
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.55
|
-0.63
|
-0.08
|
-14.55%
|
|
2022-06-30
|
-0.60
|
-0.51
|
0.09
|
15.00%
|
|
2022-03-31
|
-0.57
|
-0.59
|
-0.02
|
-3.51%
|
|
2021-12-31
|
-0.56
|
-0.58
|
-0.02
|
-3.57%
|
|
2021-09-30
|
-0.58
|
-0.47
|
0.11
|
18.97%
|
|
2021-06-30
|
-0.49
|
-0.57
|
-0.08
|
-16.33%
|
|
2021-03-31
|
-0.48
|
-0.45
|
0.03
|
6.25%
|
|
2020-12-31
|
-0.46
|
-0.84
|
-0.38
|
-82.61%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.73
|
|
2021-12-31
|
-2.07
|
|
2020-12-31
|
-6.65
|
|
2019-12-31
|
-0.08
|